Resources
141 Results (showing 1 - 10)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 10/7/2019 (updated 3/25/2024)
Join HRSA’s Bureau of Health Workforce regional team to learn more about NHSC as a provider recruitment and retention tool in rural communities.
Posted 10/7/2019 (updated 3/25/2024)
Meeting the Workforce Challenges of the Opioid Crisis in Rural America Webinar Presentation and Materials
Posted 2/9/2022 (updated 3/26/2024)
Summary of innovation abstracts that were presented at the National Academy of Medicine’s recent Stigma of Addiction Summit.
Posted 7/26/2023 (updated 3/26/2024)
This session covered key findings from the RCORP-Behavioral Health Care Support Year 1 Noncompeting Continuation Report.
Posted 7/26/2023 (updated 3/26/2024)
During this session, the Rural Behavioral Health Workforce Centers (RBHWCs) shared their collaborative project: a central resource hub for new workers looking to join the behavioral health workforce and a marketing campaign centering the value and roles of peer supports.
Posted 7/26/2023 (updated 3/26/2024)
RSV 2023: 11:30 a.m. - 12:00 p.m. Wrap up and Grantee Recognition (Day 2)
Posted 7/31/2023 (updated 3/26/2024)
At the end of July 2023, the U.S. Food and Drug Administration approved a second over-the-counter naloxone nasal spray product, RiVive. The agency who received the approval to manufacture the product, Harm Reduction Therapeutics, does not yet have a timeline of availability and decision on pricing.
Posted 8/29/2023 (updated 3/26/2024)
This engaging webinar provided an overview of an invaluable resource that harnesses the wisdom of dozens of harm reduction experts. "Harm Reduction Hacks" offers important insights, tips, and tricks.
Posted 3/3/2022 (updated 3/26/2024)
Drug overdose is a nationwide epidemic that claimed the lives of over 100,000 people in the United States in the past year. Opioids, either alone or in combination with other drugs or alcohol, were responsible for approximately 70 percent of these deaths. Many of those 70,000 people would be alive today if they had been administered the opioid antagonist naloxone and, where needed, other emergency care.
Posted 3/21/2022 (updated 3/27/2024)
NIDAMED’s mission is to develop science-based resources for health professionals and those in training about screening, addressing, and treating addiction.